Serum interleukin 8 (IL-8) may serve as a biomarker of response to immuno-oncology (I-O) therapy. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results